Chiron Capital Management’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-448
| Closed | -$4.75K | – | 120 |
|
|
2023
Q4 | $4.75K | Sell |
448
-65
| -13% | -$690 | ﹤0.01% | 117 |
|
|
2023
Q3 | $10.2K | Sell |
513
-18
| -3% | -$356 | 0.01% | 112 |
|
|
2023
Q2 | $40.6K | Sell |
531
-15
| -3% | -$1.15K | 0.03% | 113 |
|
|
2023
Q1 | $51.6K | Sell |
546
-160
| -23% | -$15.1K | 0.04% | 121 |
|
|
2022
Q4 | $68.7K | Sell |
706
-73
| -9% | -$7.11K | 0.05% | 122 |
|
|
2022
Q3 | $201K | Sell |
779
-51
| -6% | -$13.2K | 0.14% | 107 |
|
|
2022
Q2 | $154K | Sell |
830
-136
| -14% | -$25.2K | 0.1% | 117 |
|
|
2022
Q1 | $95K | Buy |
966
+171
| +22% | +$16.8K | 0.06% | 121 |
|
|
2021
Q4 | $130K | Sell |
795
-525
| -40% | -$85.8K | 0.09% | 106 |
|
|
2021
Q3 | $360K | Sell |
1,320
-20
| -1% | -$5.46K | 0.26% | 70 |
|
|
2021
Q2 | $531K | Buy |
1,340
+8
| +0.6% | +$3.17K | 0.44% | 48 |
|
|
2021
Q1 | $719K | Sell |
1,332
-8
| -0.6% | -$4.32K | 0.61% | 31 |
|
|
2020
Q4 | $507K | Sell |
1,340
-3
| -0.2% | -$1.14K | 0.42% | 45 |
|
|
2020
Q3 | $508K | Buy |
+1,343
| New | +$508K | 0.41% | 39 |
|